Home
Advertise with Us
Contact
Daily Deals
Translate to...
Toggle navigation
Categories
India
Latest News
Gujarat News
All India
World News
Latest World News
News in Hindi
News in Gujarati
All World News
Business News
India Business News
Share Market Tips
All Business News
Sports
Latest Sports News
Sports News in Hindi
All Sports
Entertainment
News in English
News in Hindi
All Entertainment
Health
World News
India News
All Health
Videos
Indian Food Recipes
Live News
Funny Video
Sadhguru - Yoga, Meditation & Spirituality
Yoga for Beginners – Daily Yoga Workout at Home
Informative Videos
Ayurvedic Upchar
All Videos
Horoscope
More...
BLOG
Business Tips
Current Openings
Home & life
Marketing
Finance & Investment
Motivation
All More...
Home
/
Health
/
India News
/
Remdesivir sells at 10x prices, NPPA unable to regulate as it's not notified as a 'drug'
Remdesivir sells at 10x prices, NPPA unable to regulate as it's not notified as a 'drug'
2020-7-30 12:30 pm
Health
→
India News
141
0
0
The NPPA can only control prices of devices and products that are defined as drugs under the Drugs and Cosmetics Act. A product or device that is not notified as a drug goes out of the NPPA's purview.
remdesivir
sells
prices
unable
regulate
notified
E-Mail
Facebook
LinkedIn
Twitter
Pinterest
VK
Prev
CM ગેહલોતે આજે હોટલમાં ધારાસભ્ય પક્ષની બેઠક...
Next
India#39;s US envoy discusses trade, investment...
You May Also Like
Crypto Comeback: Examining the surge in crypto...
Ivy League prices are pushing $90,000 a year
Cryptocurrency Prices Today March 29: Bitcoin,...
Gold price today: Rates see a fall in major...
Zydus Lifesciences gets USFDA nod to market...
SBI sells loan of Atibir Industries to CFM ARC
1
ACME Fools | Looney Tunes & The Wizard of Oz Mash-Up! | @wbkids
2
Shocking Satellite Images Reveal Mississippi Town "Lies In Ruins"
3
क्यों केएल राहुल के करियर के लिए अहम है आईपीएल 2023?
4
Kotak Mahindra Bank arm raises $1.25 billion for 2nd special situations fund
5
Rajinikanth Chose THIS Director For His Last Film? Whopping Amount Given As Advance? Here’s What We Know!